Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function
- PMID: 23798412
- PMCID: PMC3732973
- DOI: 10.1073/pnas.1309493110
Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function
Abstract
Cardiovascular disorders are the leading cause of morbidity and mortality in the developed world, and hypertrophic cardiomyopathy (HCM) is among the most frequently occurring inherited cardiac disorders. HCM is caused by mutations in the genes encoding the fundamental force-generating machinery of the cardiac muscle, including β-cardiac myosin. Here, we present a biomechanical analysis of the HCM-causing mutation, R453C, in the context of human β-cardiac myosin. We found that this mutation causes a ∼30% decrease in the maximum ATPase of the human β-cardiac subfragment 1, the motor domain of myosin, and a similar percent decrease in the in vitro velocity. The major change in the R453C human β-cardiac subfragment 1 is a 50% increase in the intrinsic force of the motor compared with wild type, with no appreciable change in the stroke size, as observed with a dual-beam optical trap. These results predict that the overall force of the ensemble of myosin molecules in the muscle should be higher in the R453C mutant compared with wild type. Loaded in vitro motility assay confirms that the net force in the ensemble is indeed increased. Overall, this study suggests that the R453C mutation should result in a hypercontractile state in the heart muscle.
Keywords: heart disease; optical trapping; single-molecule force measurements.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Comment in
-
Mutation that causes hypertrophic cardiomyopathy increases force production in human β-cardiac myosin.Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12507-8. doi: 10.1073/pnas.1310669110. Epub 2013 Jul 12. Proc Natl Acad Sci U S A. 2013. PMID: 23852727 Free PMC article. No abstract available.
Similar articles
-
The hypertrophic cardiomyopathy myosin mutation R453C alters ATP binding and hydrolysis of human cardiac β-myosin.J Biol Chem. 2014 Feb 21;289(8):5158-67. doi: 10.1074/jbc.M113.511204. Epub 2013 Dec 16. J Biol Chem. 2014. PMID: 24344137 Free PMC article.
-
Mutation that causes hypertrophic cardiomyopathy increases force production in human β-cardiac myosin.Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12507-8. doi: 10.1073/pnas.1310669110. Epub 2013 Jul 12. Proc Natl Acad Sci U S A. 2013. PMID: 23852727 Free PMC article. No abstract available.
-
Dilated cardiomyopathy myosin mutants have reduced force-generating capacity.J Biol Chem. 2018 Jun 8;293(23):9017-9029. doi: 10.1074/jbc.RA118.001938. Epub 2018 Apr 17. J Biol Chem. 2018. PMID: 29666183 Free PMC article.
-
Hypertrophic Cardiomyopathy: Diverse Pathophysiology Revealed by Genetic Research, Toward Future Therapy.Keio J Med. 2020 Dec 25;69(4):77-87. doi: 10.2302/kjm.2019-0012-OA. Epub 2020 Mar 28. Keio J Med. 2020. PMID: 32224552 Review.
-
Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.Cardiovasc Res. 1999 Oct;44(1):20-36. doi: 10.1016/s0008-6363(99)00213-8. Cardiovasc Res. 1999. PMID: 10615387 Review.
Cited by
-
Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic Cardiomyopathy.ACS Nano. 2021 Jun 22;15(6):10203-10216. doi: 10.1021/acsnano.1c02242. Epub 2021 Jun 1. ACS Nano. 2021. PMID: 34060810 Free PMC article.
-
miR-30 family microRNAs regulate myogenic differentiation and provide negative feedback on the microRNA pathway.PLoS One. 2015 Feb 17;10(2):e0118229. doi: 10.1371/journal.pone.0118229. eCollection 2015. PLoS One. 2015. PMID: 25689854 Free PMC article.
-
Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.Proc Natl Acad Sci U S A. 2018 Oct 30;115(44):11238-11243. doi: 10.1073/pnas.1802967115. Epub 2018 Oct 15. Proc Natl Acad Sci U S A. 2018. PMID: 30322937 Free PMC article.
-
The hypertrophic cardiomyopathy myosin mutation R453C alters ATP binding and hydrolysis of human cardiac β-myosin.J Biol Chem. 2014 Feb 21;289(8):5158-67. doi: 10.1074/jbc.M113.511204. Epub 2013 Dec 16. J Biol Chem. 2014. PMID: 24344137 Free PMC article.
-
Do Actomyosin Single-Molecule Mechanics Data Predict Mechanics of Contracting Muscle?Int J Mol Sci. 2018 Jun 25;19(7):1863. doi: 10.3390/ijms19071863. Int J Mol Sci. 2018. PMID: 29941816 Free PMC article. Review.
References
-
- Maron BJ, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92(4):785–789. - PubMed
-
- Ramaraj R. Hypertrophic cardiomyopathy: Etiology, diagnosis, and treatment. Cardiol Rev. 2008;16(4):172–180. - PubMed
-
- Geisterfer-Lowrance AA, et al. A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation. Cell. 1990;62(5):999–1006. - PubMed
-
- Frey N, Luedde M, Katus HA. Mechanisms of disease: Hypertrophic cardiomyopathy. Nat Rev Cardiol. 2012;9(2):91–100. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical